Bottom line
How much do PRHSX and FSPHX overlap?
49% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 46.8% of PRHSX's assets and 38.4% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings PRHSX and FSPHX have in common
| Holding | % of PRHSX | % of FSPHX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 14.28% | 8.03% | 8.03% |
| Johnson & Johnson | 6.63% | 4.91% | 4.91% |
| Unitedhealth Group Inc | 5.99% | 3.49% | 3.49% |
| Abbvie Inc | 5.10% | 2.03% | 2.03% |
| Merck & Co. Inc. | 4.01% | 1.60% | 1.60% |
| Gilead Sciences Inc | 2.82% | 2.21% | 2.21% |
| Thermo Fisher Scientific Inc | 2.52% | 4.33% | 2.52% |
| Natera Inc | 1.44% | 1.27% | 1.27% |
| Danaher Corp | 1.43% | 6.89% | 1.43% |
| Cvs Health Corp | 0.94% | 1.29% | 0.94% |
| Moderna Therapeutics Inc | 0.83% | 1.18% | 0.83% |
| Brightspring Health Services | 0.82% | 1.23% | 0.82% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PRHSX
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
- Intuitive Surgical Inc — 1.87%
- Amgen Inc — 1.82%
- Stryker Corp — 1.78%
- Elevance Health Inc — 1.53%
- Guardant Health Inc — 1.23%
- Cardinal Health Inc — 1.03%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- Protagonist Therapeutics Inc — 0.85%
Only in FSPHX
- Alnylam Pharmaceuticals Inc — 2.40%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
- Ucb Sa — 2.03%
- Bio Techne Corp — 1.70%
- Argenx Se — 1.56%
- Nuvalent Inc — 1.28%
- Viatris Inc — 1.20%
- Cencora Inc — 1.14%
- West Pharmaceutical Svcs Inc — 1.12%
- Agilent Technologies Inc — 1.10%
- Edwards Lifesciences Corp — 1.09%
Asset mix
| Asset type | PRHSX | FSPHX |
|---|---|---|
| Stocks | 96.4% | 97.7% |
| Preferred stock | 3.0% | 2.0% |
| Cash & short-term funds | 0.7% | 2.4% |
| Bonds | 0.2% | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | PRHSX | FSPHX |
|---|---|---|
| US | 92.6% | 87.0% |
| NL | 1.0% | 2.4% |
| DK | 0.7% | 2.2% |
| GB | 1.7% | 2.1% |
| BE | — | 2.0% |
| CH | 0.5% | 1.4% |
| KY | 0.5% | 1.4% |
| CA | 0.6% | 1.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PRHSX and FSPHX overlap?
What stocks do PRHSX and FSPHX have in common?
Should I own both PRHSX and FSPHX?
Which holds more stocks, PRHSX or FSPHX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.